Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Mukonzo JK"" wg kryterium: Autor


Wyświetlanie 1-11 z 11
Tytuł:
Poor immunological recovery among severely immunosuppressed antiretroviral therapy-naïve Ugandans
Autorzy:
Nanzigu S
Kiguba R
Kabanda J
Mukonzo JK
Waako P
Kityo C
Makumbi F
Pokaż więcej
Temat:
Immunologic diseases. Allergy
RC581-607
Źródło:
HIV/AIDS: Research and Palliative Care, Vol 2013, Iss default, Pp 309-319 (2013)
Opis pliku:
electronic resource
Relacje:
http://www.dovepress.com/poor-immunological-recovery-among-severely-immunosuppressed-antiretrov-a15215; https://doaj.org/toc/1179-1373
Dostęp URL:
https://doaj.org/article/8c6733e8cddb4c2da21419292ab0f73d  Link otwiera się w nowym oknie
Czasopismo naukowe
Tytuł:
Over-the-counter suboptimal dispensing of antibiotics in Uganda
Autorzy:
Mukonzo JK
Namuwenge PM
Okure G
Mwesige B
Namusisi OK
Mukanga D
Pokaż więcej
Temat:
Medicine (General)
R5-920
Źródło:
Journal of Multidisciplinary Healthcare, Vol 2013, Iss default, Pp 303-310 (2013)
Opis pliku:
electronic resource
Relacje:
http://www.dovepress.com/over-the-counter-suboptimal-dispensing-of-antibiotics-in-uganda-a14109; https://doaj.org/toc/1178-2390
Dostęp URL:
https://doaj.org/article/db1a31a1a6a246f9bd0db2e0f7a2d6c8  Link otwiera się w nowym oknie
Czasopismo naukowe
Tytuł:
Tips for charting the course of a successful health research career
Autorzy:
Mbuagbaw L
Morfaw F
Kunda JE
Mukonzo JK
Kastner J
Zhang S
Kokolo M
Thabane L
Pokaż więcej
Temat:
Medicine (General)
R5-920
Źródło:
Journal of Multidisciplinary Healthcare, Vol 2013, Iss default, Pp 163-168 (2013)
Opis pliku:
electronic resource
Relacje:
http://www.dovepress.com/tips-for-charting-the-course-of-a-successful-health-research-career-a12860; https://doaj.org/toc/1178-2390
Dostęp URL:
https://doaj.org/article/e9246a2550164986afb83ac34f800dcf  Link otwiera się w nowym oknie
Czasopismo naukowe
Tytuł:
Evaluation of the effects of Artemisia Annua L. and Moringa Oleifera Lam. on CD4 count and viral load among PLWH on ART at Mbarara Regional Referral Hospital: a double-blind randomized controlled clinical trial.
Autorzy:
Twinomujuni SS; Department of Pharmacy, Mbarara University of Science and Technology, P.O. Box 1410, Mbarara, Uganda. .
Atukunda EC; Department of Pharmacy, Mbarara University of Science and Technology, P.O. Box 1410, Mbarara, Uganda.
Mukonzo JK; Department of Pharmacology and Therapeutics, School of Biomedical Sciences, College of Health Sciences, Makerere University, P.O. Box 7062, Kampala, Uganda.
Nicholas M; Department of Pharmacy, Mbarara University of Science and Technology, P.O. Box 1410, Mbarara, Uganda.
Roelofsen F; Action for Natural Medicine in the Tropics (ANAMED INTERNATIONAL), Winnenden, Germany.
Ogwang PE; Department of Pharmacy, Mbarara University of Science and Technology, P.O. Box 1410, Mbarara, Uganda.
Pokaż więcej
Źródło:
AIDS research and therapy [AIDS Res Ther] 2024 Apr 16; Vol. 21 (1), pp. 22. Date of Electronic Publication: 2024 Apr 16.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
HIV Infections*
Moringa oleifera*
Artemisia annua*
Anti-HIV Agents*/therapeutic use
Humans ; Viral Load ; Uganda ; Anti-Retroviral Agents/therapeutic use ; Hospitals ; CD4 Lymphocyte Count ; Referral and Consultation
Czasopismo naukowe
Tytuł:
Expanding regulatory science: Regulatory complementarity and reliance.
Autorzy:
Mukonzo JK; Department of Pharmacology & Therapeutics, Makerere University, College of Health Science, Kampala, Uganda.
Ndagije HB; National Drug Authority, Kampala, Uganda.
Sabblah GT; Safety Monitoring Department, Food and Drugs Authority (FDA), Accra, Ghana.
Mathenge W; Pharmacovigilance Competence Center Limited, Nairobi, Kenya.
Price DA; DebateGraph, Somerset, UK.
Grasela TH; Azimuth Global Health Consulting, LLC, Amherst, New York, USA.
Pokaż więcej
Źródło:
Clinical and translational science [Clin Transl Sci] 2024 Jan; Vol. 17 (1), pp. e13683. Date of Electronic Publication: 2023 Nov 22.
Typ publikacji:
Journal Article
MeSH Terms:
Developing Countries*
Drug and Narcotic Control*
Humans
Czasopismo naukowe
Tytuł:
Regulatory insight from low-income countries.
Autorzy:
Mukonzo JK; Department of Pharmacology & Therapeutics, Makerere University, College of Health Science, Uganda.
Price DA; DebateGraph, Somerset, UK.
Grasela TH; School of Pharmacy, University at Buffalo, Buffalo, NY 14260, USA.; Azimuth Global Health Consulting, LLC, Amherst, NY 14226, USA.
Pokaż więcej
Źródło:
Science (New York, N.Y.) [Science] 2022 Oct 21; Vol. 378 (6617), pp. 256. Date of Electronic Publication: 2022 Oct 20.
Typ publikacji:
Letter; Comment
MeSH Terms:
Developing Countries*
Poverty*
Information Dissemination*
United States Food and Drug Administration*
Income
Opinia redakcyjna
Tytuł:
Application of the anatomical chemical system/defined daily doses: Challenges and way forward for resource-limited countries.
Autorzy:
Nantongo H; Department of Pharmacology & Therapeutics, Makerere University College of Health Sciences, Kampala, Uganda.; Department of Nursing, Faculty of Medicine, Mbarara University of Science and Technology, Mbarara, Uganda.
Batwaala V; Community Health Department, Faculty of Medicine, Mbarara University of Science and Technology, Mbarara, Uganda.; Directorate of Research & Graduate Training, Mbarara University of Science & Technology, Mbarara, Uganda.
Nambasa V; Pharmacovigilance Unit, National Drug Authority, Kampala, Uganda.
Mukonzo JK; Department of Pharmacology & Therapeutics, Makerere University College of Health Sciences, Kampala, Uganda.
Pokaż więcej
Źródło:
Journal of clinical pharmacy and therapeutics [J Clin Pharm Ther] 2022 Feb; Vol. 47 (2), pp. 135-138. Date of Electronic Publication: 2021 Jul 12.
Typ publikacji:
Journal Article
MeSH Terms:
Drug Utilization/*standards
Developing Countries ; Drug-Related Side Effects and Adverse Reactions/epidemiology ; Humans ; Medical Overuse/prevention & control ; Patient-Centered Care ; World Health Organization
Czasopismo naukowe
Tytuł:
A comparative study of logistic regression based machine learning techniques for prediction of early virological suppression in antiretroviral initiating HIV patients.
Autorzy:
Bisaso KR; Makerere University Infectious Diseases Institute, P.O. Box 7072, Kampala, Uganda. .; Department of Pharmacology and Therapeutics, Makerere University College of Health Sciences, Kampala, Uganda. .; Breakthrough Analytics Ltd, Kampala, Uganda. .
Karungi SA; Department of Pharmacology and Therapeutics, Makerere University College of Health Sciences, Kampala, Uganda.; Breakthrough Analytics Ltd, Kampala, Uganda.
Kiragga A; Makerere University Infectious Diseases Institute, P.O. Box 7072, Kampala, Uganda.
Mukonzo JK; Department of Pharmacology and Therapeutics, Makerere University College of Health Sciences, Kampala, Uganda.
Castelnuovo B; Makerere University Infectious Diseases Institute, P.O. Box 7072, Kampala, Uganda.
Pokaż więcej
Źródło:
BMC medical informatics and decision making [BMC Med Inform Decis Mak] 2018 Sep 04; Vol. 18 (1), pp. 77. Date of Electronic Publication: 2018 Sep 04.
Typ publikacji:
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Logistic Models*
Machine Learning*
Anti-HIV Agents/*therapeutic use
HIV Infections/*drug therapy
Adult ; Antiretroviral Therapy, Highly Active ; CD4 Lymphocyte Count ; Cohort Studies ; Female ; Humans ; Male ; Predictive Value of Tests ; Treatment Outcome ; Viral Load
Czasopismo naukowe
Tytuł:
Pharmacogenetic-based efavirenz dose modification: suggestions for an African population and the different CYP2B6 genotypes.
Autorzy:
Mukonzo JK; Department of Pharmacology and Therapeutics, College of Health Sciences, Makerere University, Kampala, Uganda ; CIHR, Canadian HIV Trials Network, Vancouver, British Columbia, Canada.
Owen JS; School of Pharmacy, Union University, Jackson, Tennessee, United States of America.
Ogwal-Okeng J; Department of Pharmacology and Therapeutics, College of Health Sciences, Makerere University, Kampala, Uganda.
Kuteesa RB; Department of Pharmacology and Therapeutics, College of Health Sciences, Makerere University, Kampala, Uganda.
Nanzigu S; Department of Pharmacology and Therapeutics, College of Health Sciences, Makerere University, Kampala, Uganda.
Sewankambo N; Department of Pharmacology and Therapeutics, College of Health Sciences, Makerere University, Kampala, Uganda.
Thabane L; Departments of Clinical Epidemiology and Biostatistics, Pediatrics and Anaesthesia, McMaster University, Hamilton, Ontario, Canada ; Biostatistics Unit, St. Joseph's Healthcare-Hamilton, Hamilton, Ontario, Canada.
Gustafsson LL; Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska University Hospital-Huddinge, Karolinska Institutet, Stockholm, Sweden.
Ross C; Division of Translational Therapeutics, University of British Columbia, Vancouver, British Columbia, Canada.
Aklillu E; Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska University Hospital-Huddinge, Karolinska Institutet, Stockholm, Sweden.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2014 Jan 31; Vol. 9 (1), pp. e86919. Date of Electronic Publication: 2014 Jan 31 (Print Publication: 2014).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Aryl Hydrocarbon Hydroxylases/*genetics
Benzoxazines/*therapeutic use
HIV Infections/*drug therapy
HIV Infections/*genetics
ATP Binding Cassette Transporter, Subfamily B ; ATP Binding Cassette Transporter, Subfamily B, Member 1/genetics ; Adult ; Alkynes ; Area Under Curve ; Benzoxazines/pharmacokinetics ; Cyclopropanes ; Cytochrome P-450 CYP2B6 ; Cytochrome P-450 CYP3A/genetics ; Dose-Response Relationship, Drug ; Drug Therapy, Combination ; Female ; Genotype ; Humans ; Lamivudine/therapeutic use ; Male ; Middle Aged ; Mutation ; Pharmacogenetics ; Reverse Transcriptase Inhibitors/pharmacokinetics ; Reverse Transcriptase Inhibitors/therapeutic use ; Treatment Outcome ; Uganda ; Zidovudine/therapeutic use
Czasopismo naukowe
Tytuł:
Influence of efavirenz pharmacokinetics and pharmacogenetics on neuropsychological disorders in Ugandan HIV-positive patients with or without tuberculosis: a prospective cohort study.
Autorzy:
Mukonzo JK; Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, SE- 141 86, Stockholm, Sweden.
Okwera A
Nakasujja N
Luzze H
Sebuwufu D
Ogwal-Okeng J
Waako P
Gustafsson LL
Aklillu E
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2013 Jun 04; Vol. 13, pp. 261. Date of Electronic Publication: 2013 Jun 04.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Anti-HIV Agents/*blood
Benzoxazines/*pharmacokinetics
HIV Infections/*drug therapy
HIV Infections/*metabolism
Mental Disorders/*drug therapy
Mental Disorders/*metabolism
Tuberculosis/*metabolism
Adult ; Alkynes ; Anti-HIV Agents/adverse effects ; Anti-HIV Agents/pharmacokinetics ; Antibiotics, Antitubercular/therapeutic use ; Antiretroviral Therapy, Highly Active ; Aryl Hydrocarbon Hydroxylases/genetics ; Benzoxazines/adverse effects ; Benzoxazines/blood ; Cognitive Dysfunction/drug therapy ; Cognitive Dysfunction/metabolism ; Cognitive Dysfunction/virology ; Constitutive Androstane Receptor ; Cyclopropanes ; Cytochrome P-450 CYP2B6 ; Cytochrome P-450 CYP3A/genetics ; Female ; Gene Frequency ; HIV Infections/microbiology ; HIV Infections/psychology ; Hallucinations/drug therapy ; Hallucinations/metabolism ; Hallucinations/virology ; Humans ; Kaplan-Meier Estimate ; Male ; Memory Disorders/drug therapy ; Memory Disorders/metabolism ; Memory Disorders/virology ; Mental Disorders/microbiology ; Mental Disorders/virology ; Prospective Studies ; Rifampin/therapeutic use ; Sleep Arousal Disorders/drug therapy ; Sleep Arousal Disorders/metabolism ; Sleep Arousal Disorders/virology ; Tuberculosis/drug therapy ; Tuberculosis/virology ; Uganda/epidemiology
Czasopismo naukowe
    Wyświetlanie 1-11 z 11

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies